Med-Mastodon

Gregory MSEffects of Sailing and Cooing in the Quality of Life of Multiple Sclerosis Individuals<a href="https://clinicaltrials.gov/study/NCT06915272?cond=Multiple+Sclerosis" target="_blank" rel="nofollow noopener noreferrer" translate="no">https://clinicaltrials.gov/study/NCT06915272?cond=Multiple+Sclerosis</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="tag">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="tag">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="tag">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="tag">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="tag">#botsFightMS</a>

Alessia Visconti📣 <a href="https://mas.to/tags/AI" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#AI</a> and <a href="https://mas.to/tags/healthcare" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#healthcare</a> researchers 📣The first talks from the Italian Association of Medical Statistics and Clinical Epidemiology (<a href="https://mas.to/tags/Sismec" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Sismec</a>) Working Group on <a href="https://mas.to/tags/MachineLearning" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MachineLearning</a> for <a href="https://mas.to/tags/ClinicalResearch" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ClinicalResearch</a> are now available onlineMarco Grangetto, UniTO, presented on “Foundation Models in <a href="https://mas.to/tags/Neuroimaging" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Neuroimaging</a>”, <a href="https://www.youtube.com/watch?v=Z2hLXQwKSyg&ab_channel=Sismec" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.youtube.com/watch?v=Z2hLXQwKSyg&ab_channel=Sismec</a>Maurizio Polano, CRO-Aviano IRCCS, gave a lightning talk on “Enhancing <a href="https://mas.to/tags/PrecisionMedicine" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#PrecisionMedicine</a> and <a href="https://mas.to/tags/ClinicalTrial" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ClinicalTrial</a> Methodologies by Machine Learning”, <a href="https://www.youtube.com/watch?v=Gkg6AwBWhFc&ab_channel=Sismec" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.youtube.com/watch?v=Gkg6AwBWhFc&ab_channel=Sismec</a>

Gregory MSHome-Based Transcranial Direct Current Stimulation (tDCS) for Depression in Multiple Sclerosis (MS)<a href="https://clinicaltrials.gov/study/NCT06901687?cond=Multiple+Sclerosis" target="_blank" rel="nofollow noopener noreferrer" translate="no">https://clinicaltrials.gov/study/NCT06901687?cond=Multiple+Sclerosis</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="tag">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="tag">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="tag">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="tag">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="tag">#botsFightMS</a>

Gregory MSAn Open-Label, Parallel-Group Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of Ocrelizumab in Children and Adolescents with Relapsing-Remitting Multiple Sclerosis<a href="https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2023-507313-94-00" target="_blank" rel="nofollow noopener noreferrer" translate="no">https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2023-507313-94-00</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="tag">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="tag">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="tag">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="tag">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="tag">#botsFightMS</a>

Gregory MSA Study of Allogeneic Hematopoietic Cell Transplantation for Primary Progressive Multiple Sclerosis<a href="https://clinicaltrials.gov/study/NCT06900192?cond=Multiple+Sclerosis" target="_blank" rel="nofollow noopener noreferrer" translate="no">https://clinicaltrials.gov/study/NCT06900192?cond=Multiple+Sclerosis</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="tag">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="tag">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="tag">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="tag">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="tag">#botsFightMS</a>

Gregory MSMetabolic Imaging of Neurological Disease<a href="https://clinicaltrials.gov/study/NCT06900244?cond=Multiple+Sclerosis" target="_blank" rel="nofollow noopener noreferrer" translate="no">https://clinicaltrials.gov/study/NCT06900244?cond=Multiple+Sclerosis</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="tag">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="tag">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="tag">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="tag">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="tag">#botsFightMS</a>

Gregory MSP3-IMU-838-RMS-02 - A Multi-Center, Randomized, Double-Blinded Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 versus Placebo in Adults with Relapsing Multiple Sclerosis (ENSURE-2)<a href="https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-514619-88-00" target="_blank" rel="nofollow noopener noreferrer" translate="no">https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-514619-88-00</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="tag">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="tag">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="tag">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="tag">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="tag">#botsFightMS</a>

Gregory MSA Phase IV, Multicenter, Open-Label Study Evaluating B-Cell Levels in Infants Potentially Exposed to Ocrelizumab During Pregnancy – The MINORE Study<a href="https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-510974-25-00" target="_blank" rel="nofollow noopener noreferrer" translate="no">https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-510974-25-00</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="tag">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="tag">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="tag">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="tag">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="tag">#botsFightMS</a>

Gregory MSA Study of Multiple Sclerosis Routine Clinical Practice: Impact on Adherence and Clinical Outcomes of Ofatumumab Treated Patients<a href="https://clinicaltrials.gov/study/NCT06897657?cond=Multiple+Sclerosis" target="_blank" rel="nofollow noopener noreferrer" translate="no">https://clinicaltrials.gov/study/NCT06897657?cond=Multiple+Sclerosis</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="tag">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="tag">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="tag">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="tag">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="tag">#botsFightMS</a>

Europe Says<a href="https://www.europesays.com/1948031/" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.europesays.com/1948031/</a> Tempest Reports Year End 2024 Financial Results and Provides Business Update <a href="https://pubeurope.com/tags/america" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#america</a> <a href="https://pubeurope.com/tags/atezolizumab" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#atezolizumab</a> <a href="https://pubeurope.com/tags/bevacizumab" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#bevacizumab</a> <a href="https://pubeurope.com/tags/business" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#business</a> <a href="https://pubeurope.com/tags/ClinicalTrial" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ClinicalTrial</a> <a href="https://pubeurope.com/tags/FDA" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#FDA</a> <a href="https://pubeurope.com/tags/UnitedStates" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#UnitedStates</a> <a href="https://pubeurope.com/tags/UnitedStatesOfAmerica" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#UnitedStatesOfAmerica</a> <a href="https://pubeurope.com/tags/unresectable" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#unresectable</a> <a href="https://pubeurope.com/tags/US" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#US</a> <a href="https://pubeurope.com/tags/USA" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#USA</a>

Gregory MSRehabilitative Protocols in Progressive Multiple Sclerosis Treated with Anti CD20 Monoclonal Antibodies<a href="https://clinicaltrials.gov/study/NCT06894940?cond=Multiple+Sclerosis" target="_blank" rel="nofollow noopener noreferrer" translate="no">https://clinicaltrials.gov/study/NCT06894940?cond=Multiple+Sclerosis</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="tag">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="tag">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="tag">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="tag">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="tag">#botsFightMS</a>

Gregory MSNasal Foralumab in Patients with Non-Active Secondary Progressive Multiple Sclerosis<a href="https://clinicaltrials.gov/study/NCT06890923?cond=Multiple+Sclerosis" target="_blank" rel="nofollow noopener noreferrer" translate="no">https://clinicaltrials.gov/study/NCT06890923?cond=Multiple+Sclerosis</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="tag">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="tag">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="tag">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="tag">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="tag">#botsFightMS</a>

Gregory MSSelf-Directed Positive Psychology Intervention for Newly Diagnosed Multiple Sclerosis<a href="https://clinicaltrials.gov/study/NCT06891937?cond=Multiple+Sclerosis" target="_blank" rel="nofollow noopener noreferrer" translate="no">https://clinicaltrials.gov/study/NCT06891937?cond=Multiple+Sclerosis</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="tag">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="tag">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="tag">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="tag">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="tag">#botsFightMS</a>

Gregory MSAn open-label, multi-center, phase 1&<a href="https://med-mastodon.com/tags/x2F" class="mention hashtag" rel="tag">#x2F</a>;2 study to assess safety, efficacy, and cellular kinetics of YTB323 in participants with Relapsing Multiple Sclerosis with breakthrough disease activity during previous treatment with a highly efficacious therapy<a href="https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-512714-18-00" target="_blank" rel="nofollow noopener noreferrer" translate="no">https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-512714-18-00</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="tag">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="tag">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="tag">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="tag">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="tag">#botsFightMS</a>

Gregory MSTestOsterone TreatmEnt on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis (TOTEM-RRMS)<a href="https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-517845-14-00" target="_blank" rel="nofollow noopener noreferrer" translate="no">https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-517845-14-00</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="tag">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="tag">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="tag">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="tag">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="tag">#botsFightMS</a>

Gregory MSEvaluating efficacy of a modified regimen of ublituximab (ENHANCE)<a href="https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-519284-18-00" target="_blank" rel="nofollow noopener noreferrer" translate="no">https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-519284-18-00</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="tag">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="tag">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="tag">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="tag">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="tag">#botsFightMS</a>

Gregory MSCladribine Tablets as an Exit Therapy Strategy<a href="https://clinicaltrials.gov/study/NCT06887426?cond=Multiple+Sclerosis" target="_blank" rel="nofollow noopener noreferrer" translate="no">https://clinicaltrials.gov/study/NCT06887426?cond=Multiple+Sclerosis</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="tag">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="tag">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="tag">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="tag">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="tag">#botsFightMS</a>

Gregory MSEducational Programs Based on Healthy Habits to Improve Quality of Life and Psychosocial Profile in Women with Neurodegenerative Diseases: the ADVICE Protocol Study (Phase 2)<a href="https://clinicaltrials.gov/study/NCT06884579?cond=Multiple+Sclerosis" target="_blank" rel="nofollow noopener noreferrer" translate="no">https://clinicaltrials.gov/study/NCT06884579?cond=Multiple+Sclerosis</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="tag">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="tag">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="tag">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="tag">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="tag">#botsFightMS</a>

Gregory MSA Randomized, Double-blind, Parallel-group Study to Compare Pharmacokinetics, Pharmacodynamics, Clinical Effects, and Safety between ABP 692 and Ocrevus® (Ocrelizumab) in Subjects with Relapsing-remitting Multiple Sclerosis<a href="https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-512914-16-00" target="_blank" rel="nofollow noopener noreferrer" translate="no">https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-512914-16-00</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="tag">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="tag">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="tag">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="tag">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="tag">#botsFightMS</a>

Gregory MSA single-arm, prospective, multicentre, open-label study to evaluate ofatumumab treatment effectiveness and patient-reported outcomes (PRO) in patients with relapsing multiple sclerosis (RMS) transitioning from fumarate-based RMS approved therapies or fingolimod.<a href="https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2023-507493-41-00" target="_blank" rel="nofollow noopener noreferrer" translate="no">https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2023-507493-41-00</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="tag">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="tag">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="tag">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="tag">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="tag">#botsFightMS</a>

Recent searches

Search options

Administered by:

Server stats:

#clinicaltrial